Fundamentals of Medical & Case Management of Drug-Susceptible TB

Registration for this training ended on Mon, 07/24/2023 - 19:00

Training Date: Wednesday, August 23, 2023  [virtual training offered via Zoom]

Training Time: 12:00 - 2:30 pm Pacific Time. (All of our virtual trainings are in Pacific Time. If you are unsure about the time zone differences, please use the Time Converter)

Cost: There is no fee for this training.

Credit: This training is approved for up to 2.5 nursing continuing education hour (see below). Certificates will be available approximately 12 weeks after the training.

Target Audience: This training is intended for nurses and case managers who provide care for TB patients within the public health setting. It is an entry-level training for nurses/case managers who are within their first year or two of providing TB case management for patients with active tuberculosis.

Description: This training will cover the fundamentals of medical and case management of patients with drug-susceptible tuberculosis. Participants will also apply what they learn to case scenarios to reinforce the concepts.

This virtual training is part of the Curry Center’s Tuberculosis Case Management and Contact Investigation Intensive (CMCI) core training. The 2023 virtual CMCI series is designed for tuberculosis case managers and public health nurses who deliver case management services to patients with active or latent TB within the public health setting. For more information about this series, and other core training opportunities, please visit our website or email us at

Training Objectives:

By the end of the training, participants will be able to:

  • describe the key components of TB case management
  • identify the recommended regimens and first-line medications for treating DS-TB disease
  • identify the baseline evaluations that should be obtained prior to starting treatment for DS-TB
  • describe common side effects and the associated monitoring required for individual first-line anti-TB drugs
  • monitor and document clinical findings to evaluate for response to TB treatment
  • state several criteria for when treatment for drug-susceptible TB should be extended to at least 9 months

Virtual Training Format: interactive lecture, case studies and Q&A/discussion



Ann Scarpita, MPH, MSN, BSN, RN TB Nurse Consultant Tuberculosis Program Colorado Department of Public Health and Environment Denver, CO


The Curry International Tuberculosis Center is approved as a provider of continuing education by the California State Board of Registered Nurses, Provider Number CEP 12308. This training is approved for up to 2.5 continuing education hour. Board requirements prevent us from offering CE credit to people who arrive more than 15 minutes after the start of the training, or leave the training early. Therefore, partial credit will not be awarded.


The Curry International Tuberculosis Center is designated as a Tuberculosis Center of Excellence for Training, Education, and Medical Consultation (TB COE) via a funded cooperative agreement with the Centers for Disease Control and Prevention. The Curry International Tuberculosis Center prioritizes learners from the western region of the United States which consists of seventeen jurisdictions: Alaska, Arizona, California (including Los Angeles, San Diego, and San Francisco), Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming, and the U.S. Pacific Island Territories.


Important: For your application to be considered, we require completion of the enrollment questions. To begin, please click Apply. Complete the enrollment questions that appear on the next page. To finish, click Submit.


Course Dates
Registration Dates
Training Format
Total Hours

United States

Training Material

Fundamentals of Medical & Case Management of Drug-Susceptible TB [Course Materials]

Additional Resources:

Nursing Guide for Managing Side Effects to Drug-resistant TB Treatment is a collaborative project between CITC and the International Council of Nurses (ICN). The guide was developed by nurses with experience in the clinical care and programmatic management of tuberculosis (TB) and drug-resistant tuberculosis (DR-TB) in both high- and low-resource settings. While this guide was developed to support nursing care of patients with DR-TB, it may also be helpful to guide the care of patients on anti-TB treatment in general who may also experience side effects related to their treatment.

The guide is designed as a reference and job aid, so nurses can quickly:

  1. Identify symptoms that may be related to TB medication
  2. Assess for severity and other potential contributors
  3. Intervene appropriately to minimize patient discomfort, reduce side effect progression, and ultimately support successful treatment completion

Date of Release: October 2018


Tuberculosis Case Management: A Guide for Nurses (A Rutgers Global Tuberculosis Institute product)

EXPOSED Chapter 1: The Global Epidemic (YouTube video)

Training Materials
Warmline Medical Consultation
Medical & Case Management of Drug-Susceptible TB_Slide Set
Learner Guide (agenda, objectives, supplemental resources)
TB Acronyms and Abbreviations
Credit page
Disclosure page
Approval Notification Date